Physician profile
Avani Patel
NPI 1154360998
$414.97
in general payments reported to CMS, 2019-2025
12 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.45 · 2020: $42.94 · 2021: $10.98 · 2022: $31.00 · 2024: $104 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $268.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $104.12 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.47 | 2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $37.06 | 2019 | |
| Alcon Vision LLC | $31.00 | 2022 | |
| Exact Sciences Corporation | $25.21 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $24.64 | 2020 | |
| Novartis Pharmaceuticals Corporation | $24.39 | 2019 | |
| Novo Nordisk INC | $21.76 | 2025 | Rybelsus, Ozempic |
| Ferring Pharmaceuticals INC. | $19.60 | 2025 | Rebyota |
| Lilly USA, LLC | $18.30 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $15.44 | 2025 | Farxiga |
| Bard Peripheral Vascular, INC. | $10.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avani Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.